Viracta Therapeutics, Inc. (VIRX) Reports In-Line Q1 EPS

Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Anthropic delays planned IPO from October to November - WSJ
• Can global equities keep rising? UBS sees these factors driving upside